Kerrisdale Advisers’s PTC Therapeutics PTCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-40,122	Closed	-$1.35M	–	15
2018 Q2	$1.35M	Buy	40,122 +4,557	+13%	+$154K	0.56%	11
2018 Q1	$962K	Buy	35,565 +565	+2%	+$15.3K	0.67%	13
2017 Q4	$584K	Buy	+35,000	New	+$584K	1.18%	8